Inhibition of α4β1 integrin increases ovarian cancer response to carboplatin.

Inhibition of α4β1 integrin increases ovarian cancer response to carboplatin.

Item
http://www.wikidata.org/entity/Q30408322
Alterations in ovarian cancer cell adhesion drive taxol resistance by increasing microtubule dynamics in a FAK-dependent manner.Actinomyosin contraction, phosphorylation of VE-cadherin, and actin remodeling enable melanoma-induced endothelial cell-cell junction disassembly.Integrin β1-mediated acquired gefitinib resistance in non-small cell lung cancer cells occurs via the phosphoinositide 3-kinase-dependent pathway.miR-199a-5p regulates β1 integrin through Ets-1 to suppress invasion in breast cancer.Contribution of very late antigen-4 (VLA-4) integrin to cancer progression and metastasis.Interactions Between Inflammatory Bowel Disease Drugs and Chemotherapy.Potential of Integrin Inhibitors for Treating Ovarian Cancer: A Literature Review.Glioblastoma in natalizumab-treated multiple sclerosis patients.
P2860

Inhibition of α4β1 integrin increases ovarian cancer response to carboplatin.

Item
http://www.wikidata.org/entity/Q30408322
description
2013 nî lūn-bûn
@nan
2013 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Inhibition of α4β1 integrin increases ovarian cancer response to carboplatin.
@ast
Inhibition of α4β1 integrin increases ovarian cancer response to carboplatin.
@en
type
label
Inhibition of α4β1 integrin increases ovarian cancer response to carboplatin.
@ast
Inhibition of α4β1 integrin increases ovarian cancer response to carboplatin.
@en
prefLabel
Inhibition of α4β1 integrin increases ovarian cancer response to carboplatin.
@ast
Inhibition of α4β1 integrin increases ovarian cancer response to carboplatin.
@en
P1433
P1476
P2093
P2860
P304
P31
P356
P407
P433
P478
P577
P698
P921
P932
P356
P1433
P1476
Inhibition of α4β1 integrin increases ovarian cancer response to carboplatin.
@en
P2093
P2860
P304
P31
P356
10.1016/J.YGYNO.2013.12.031
P407
P433
P478
P577
P698
P921
P932